Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
Price Target
Average
107.61%
Revenue Forecast
Estimate
1606.38%
EBIT
Estimate
--82.43%
Net Income
Estimate
63.91%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Geron Corporation
Wall Street analysts predict an average 1-year price target for GERN of $6 , with forecasts ranging from
a
low of
$4.5 to a high of $8 .
GERN Lowest Price Target
Wall Street Target
4.5 USD
55.71%
GERN Average Price Target
Wall Street Target
6 USD
107.61%
GERN Highest Price Target
Wall Street Target
8 USD
176.82%
REVENUE FORECAST
Revenue Forecast Chart GERN
EBIT FORECAST
EBIT Forecast Chart GERN
NET INCOME FORECAST
Net Income Chart GERN